Search results for "Splenic Neoplasms"

showing 8 items of 28 documents

Solitary splenic metastasis from nasopharyngeal carcinoma: a case report and systematic review of the literature

2016

Background: Solitary splenic metastases are a rare occurrence, and the nasopharyngeal carcinoma represents one of the most uncommon primary sources. The present study aimed to describe a rare case of a solitary single splenic metastasis from nasopharyngeal carcinoma and to assess the number of cases of isolated nasopharyngeal carcinoma metastases to the spleen reported in the literature. Main body: We describe the case of a 56-year-old man with a history of nasopharyngeal carcinoma and complete remission after chemo-radiotherapy. Three months after complete remission, positron emission tomography/ computed tomography scan revealed a hypermetabolic splenic lesion without increased metabolic …

MaleHerpesvirus 4 HumanPathologymedicine.medical_specialtySplenic metastasisBiopsymedicine.medical_treatmentSplenectomyNasopharyngeal neoplasmSplenic metastasis Nasopharyngeal carcinoma Systematic reviewSplenic NeoplasmReview03 medical and health sciencesRare Diseases0302 clinical medicineSurgical oncologyNasopharynxPositron Emission Tomography Computed TomographyBiopsymedicineCarcinomaHumansNeoadjuvant therapyNeoplasm StagingNasopharyngeal Carcinomamedicine.diagnostic_testbusiness.industrySplenic NeoplasmsCarcinomaNasopharyngeal NeoplasmsChemoradiotherapyMiddle Agedmedicine.diseaseMagnetic Resonance ImagingNeoadjuvant TherapySettore MED/18 - Chirurgia GeneraleTreatment OutcomeOncologyNasopharyngeal carcinomaLymphatic Metastasis030220 oncology & carcinogenesisSystematic reviewSplenectomyLaparoscopy030211 gastroenterology & hepatologySurgerybusinessWorld Journal of Surgical Oncology
researchProduct

Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

2011

Abstract Marginal zone B-cell lymphomas (MZLs) have been divided into 3 distinct subtypes (extranodal MZLs of mucosa-associated lymphoid tissue [MALT] type, nodal MZLs, and splenic MZLs). Nevertheless, the relationship between the subtypes is still unclear. We performed a comprehensive analysis of genomic DNA copy number changes in a very large series of MZL cases with the aim of addressing this question. Samples from 218 MZL patients (25 nodal, 57 MALT, 134 splenic, and 2 not better specified MZLs) were analyzed with the Affymetrix Human Mapping 250K SNP arrays, and the data combined with matched gene expression in 33 of 218 cases. MALT lymphoma presented significantly more frequently gain…

MalePathologyLymphomaMarginal ZoneBiochemistryExtranodal Diseaseclassification/genetics/pathologyhemic and lymphatic diseases80 and overgeneticsAged 80 and overComparative Genomic HybridizationGenomeMALT lymphomaHematologySingle NucleotideMiddle AgedMarginal zonePrognosisGene Expression Regulation NeoplasticAdult Aged Aged; 80 and over Chromosome Aberrations Comparative Genomic Hybridization DNA Fingerprinting Female Gene Expression Profiling Gene Expression Regulation; Neoplastic Genome; Human Humans Lymphoma; B-Cell; Marginal Zone; classification/genetics/pathology Male Middle Aged Polymorphism; Single Nucleotide; genetics Prognosis Splenic Neoplasms; classification/genetics/pathology Young AdultFemaleHumanAdultmedicine.medical_specialtyGenome-wide DNA profilingImmunologyBiologyPolymorphism Single NucleotideYoung AdultGenome-wide DNA profiling; marginal zone lymphomas; clinical outcome.medicineSNPHumansSplenic marginal zone lymphomaPolymorphismAgedChromosome AberrationsNeoplasticGenome HumanSplenic Marginal Zone Lymphoma; GenomicGene Expression ProfilingSplenic NeoplasmsB-CellLymphoma B-Cell Marginal ZoneCell Biologyclinical outcome.medicine.diseasemarginal zone lymphomaDNA FingerprintingLymphomaGene expression profilingGene Expression RegulationComparative genomic hybridization
researchProduct

Histologically benign metastatic meningioma: morphological and cytogenetic study. Case report.

2003

✓ The authors report on a 75-year-old man with histologically benign fibroblastic meningioma metastasizing to the lung, liver, spleen, and kidney. The original tumor exhibited a complex karyotype involving different structural and numerical anomalies associated with monosomy of chromosome 22. The implication of chromosome 1p36 was confirmed by fluorescence in situ hybridization in most interphase nuclei. Metastases occurred 4 months after incomplete resection with prior therapeutic embolization. The recurrent tumor in turn displayed anaplastic features and an increased Ki-67 labeling index. Genetic alterations in such morphologically benign meningiomas have been implicated in the malignant …

Malemedicine.medical_specialtyPathologyMonosomyLung NeoplasmsMetastasisMeningiomaMeningeal NeoplasmsMedicineHumansAgedmedicine.diagnostic_testbusiness.industrySplenic NeoplasmsMetastatic MeningiomaLiver NeoplasmsCytogeneticsmedicine.diseaseMagnetic Resonance ImagingKidney NeoplasmsBenign MeningiomaCytogenetic AnalysisbusinessMeningiomaChromosome 22Fluorescence in situ hybridizationJournal of neurosurgery
researchProduct

Splenic marginal zone lymphoma: A prognostic model for clinical use

2006

The Integruppo Italiano Linfomi (IIL) carried out a study to assess the outcomes of splenic marginal zone lymphoma and to identify prognostic factors in 309 patients. The 5-year cause-specific survival (CSS) rate was 76%. In univariate analysis, the parameters predictive of shorter CSS were hemoglobin levels below 12 g/dL (P < .001), albumin levels below 3.5 g/dL (P = .001), International Prognostic Index (IPI) scores of 2 to 3 (P < .001), lactate dehydrogenase (LDH) levels above normal (P < .001), age older than 60 years (P = .01), platelet counts below 100 000/μL (P = .04), HbsAg-positivity (P = .01), and no splenectomy at diagnosis (P = .006). Values that maintained a negative influence …

Malesplenic marginal zone lymphoma; prognostic factors; International Prognostic Index (IPI)VILLOUS LYMPHOCYTESHydro-LyaseB-CELLLongitudinal StudiePredictive Value of TestInternational Prognostic Index (IPI)BiochemistryGastroenterologyHemoglobinschemistry.chemical_compoundInternational Prognostic IndexRisk FactorsBONE-MARROW INFILTRATION; NON-HODGKINS-LYMPHOMA; C VIRUS-INFECTION; VILLOUS LYMPHOCYTES; B-CELLBONE-MARROW INFILTRATIONAge FactorLongitudinal StudiesMultivariate AnalysiAged 80 and overUnivariate analysisHematologyMortality rateAge FactorsHematologyMiddle AgedPrognosisSplenic NeoplasmSurvival RatePredictive value of testsHumanAdultmedicine.medical_specialtyLymphoma B-CellPrognosiImmunologysplenic marginal zone lymphomaDisease-Free SurvivalPredictive Value of TestsAlbuminsInternal medicineLactate dehydrogenaseAdult; Age Factors; Aged; Aged 80 and over; Albumins; Disease-Free Survival; Hemoglobins; Humans; Hydro-Lyases; Longitudinal Studies; Lymphoma B-Cell; Male; Middle Aged; Multivariate Analysis; Platelet Count; Predictive Value of Tests; Prognosis; Risk Factors; Splenic Neoplasms; Survival Rate; Models Theoretical; HematologymedicineHumansHemoglobinNON-HODGKINS-LYMPHOMASplenic marginal zone lymphomaSurvival rateHydro-LyasesAgedPlatelet Countbusiness.industrySplenic NeoplasmsAlbuminRisk Factorprognostic factorsCell BiologyModels Theoreticalmedicine.diseaseSurgerychemistryMultivariate AnalysisbusinessC VIRUS-INFECTION
researchProduct

Isolated Metachronous Splenic Metastasis from Colon Cancer: Possible Explanations for This Rare Entity

2017

The incidence of splenic metastases secondary to colorectal cancer is very low; these lesions have been more frequently reported as secondary to breast, lung, and ovarian cancer. Splenic metastases are particularly common in melanoma; their incidence has been reported as being as high as 34% at autopsy [1]. Most cases of secondary splenic metastases have been described in patients with tumors of the left colon while only few cases being reported as originating from right colon tumors (Table 1). The finding of a splenic mass in the absence of a history of malignancy suggests a primary lesion (lymphoma, hematoma, etc.), while a history of oncological disease raises the possibility of a second…

Oncologymedicine.medical_specialtyColorectal cancermedicine.medical_treatmentMEDLINESplenic Neoplasm030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansNeoplasm MetastasisAgedbusiness.industrySplenic NeoplasmsRare entityGastroenterologymedicine.diseaseRadiation therapySettore MED/18 - Chirurgia GeneraleOncology; GastroenterologyOncology030220 oncology & carcinogenesisColonic NeoplasmsFemalebusinessSplenic metastasis
researchProduct

Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma

2006

Abstract: Objectives: Solid second primary cancers (SPC) have become an issue of extensive research. The purpose of the present study was to estimate the standardised incidence ratio (SIR) and the absolute excess risk (AER) of SPC in patients with splenic marginal zone lymphoma (SMZL). Methods: We investigated the incidence of additional cancers in 129 patients consecutively diagnosed with SMZL in three Italian haematological centres, asking the cooperating doctors for additional information on initial and subsequent therapies and on the onset and type of second cancers. Results: Twelve SPC were recorded (9.3%); the 3- and 5-yr cumulative incidence rates were 5.5% and 18.3% respectively, wi…

Oncologymedicine.medical_specialtyLymphomaPopulationsplenic marginal zone lymphomaBreast cancerInternal medicinemedicinecancerHumansCumulative incidenceSplenic marginal zone lymphomaLung cancereducationAgededucation.field_of_studysplenic marginal zone lymphoma cancerbusiness.industryIncidenceSplenic Neoplasmsadditional cancerCancerNeoplasms Second PrimarySplenic lymphoma with villous lymphocytesHematologyGeneral MedicineMiddle Agedmedicine.diseaseNon-Hodgkin's lymphomabusinessEuropean Journal of Haematology
researchProduct

Re: ?Splenic marginal zone B-cell lymphoma associated with primary Sj�gren?s syndrome?

2003

We describe a 67-year-old woman with primary Sjögren's syndrome who developed a splenic marginal zone B-cell lymphoma, and complained of a dry mouth and Raynaud's phenomenon. She had splenomegaly, swollen lymph nodes and monoclonal IgM-kappa cryoglobulin. After splenectomy, Raynaud's phenomenon had improved with the decrease of cryoglobulin. This is the first case of primary Sjögren's syndrome with splenic marginal zone B-cell lymphoma to be reported.

Pathologymedicine.medical_specialtymedicine.medical_treatmentSplenectomyImmunologyCryoglobulinRheumatologyMedicineHumansB cellAgedbusiness.industrySplenic NeoplasmsLymphoma B-Cell Marginal ZoneGeneral MedicineSwollen lymph nodesmedicine.diseaseMarginal zoneCryoglobulinemiaLymphomaSplenic Neoplasmmedicine.anatomical_structureLymphatic systemSjogren's SyndromeFemalemedicine.symptombusinessHumanClinical Rheumatology
researchProduct

Synthesis of biotin-labelled dexamethasone derivatives. Novel hormone-affinity probes.

1983

A new, general methodology for 'sandwich' affinity chromatography of steroid hormone receptors is proposed, the part purification of the human spleen tumor glucocorticoid receptor is quoted as an illustration. 9-Fluoro-16 alpha-methyl-11 beta, 17-dihydroxy-1,4-androstadiene-3-one-17 beta-carboxylic acid was coupled to biotin using pentamethylenediamine (BioDex 1) as a spacer. The bifunctional derivative binds to glucocorticoid receptors and avidin-Sepharose and efficiently protects the glucocorticoid receptor against inactivation when previously added during homogenisation. We have standardized the capacity and optimum conditions for elution of receptor-BioDex-1 complexes which are bound to…

medicine.medical_treatmentBiotinBiochemistryBinding CompetitiveChromatography AffinityDexamethasoneSteroidchemistry.chemical_compoundGlucocorticoid receptorCytosolReceptors GlucocorticoidAffinity chromatographyBiotinCadaverinemedicineHumansBinding siteReceptorPolyacrylamide gel electrophoresisChromatographyBinding SitesChemistrySplenic NeoplasmsAffinity LabelsSteroid hormoneBiochemistryElectrophoresis Polyacrylamide GelEuropean journal of biochemistry
researchProduct